Chuck Walston
Contributor since: 2013
Articles
Simon Property: Down But Far From Out
Tanger: There Are 2 Sides To This Coin
Cisco: Reasonable Valuation, Fortress Financial Foundation, But No Growth Catalysts
General Electric: Just When You Thought Things Couldn't Possibly Get Worse
IBM: Why My Eye Is Fixed On Big Blue
Medical Properties Trust: Manifest Strengths Coupled With Red Flags
Nexstar: Deeply Undervalued With A Well Funded, Rapidly Growing Dividend
AT&T: A Crucial Piece Of The Puzzle Many Are Missing
To Understand UPS, You Must First Understand Amazon
Ford: A V-Shaped Recovery And Trading Below Book Value Doesn't Make This An Investment
Walgreens: Shunned By The Market - Why I See An Opportunity
Lowe's: The Model For Market-Beating Investments
Bristol-Myers Squibb: Growth And Valuation Trump Other Concerns
Microsoft: To Buy Or Not To Buy? That's Not Really The Question
Cigna: Undervalued With Strong Growth Prospects
Kroger: How The COVID-19 Crisis Could Provide Long-Term Tailwinds
Home Depot: How This Stodgy Retailer Can Provide Safe, Market-Beating Returns
If You Want To Invest In Retail, Realty Income Is A Great Candidate
Altria Group: MO Yield (8% Plus) Due To MO Problems
GE: For The 'Things Are So Bad They Can Only Get Better' Investor
L3Harris Technologies: Steady Growth Yet Insulated From COVID-19 And The Economy
Amgen: Why I'm Ready To Buy This Biotech
Carlisle Companies: Perhaps The Best Business You've Never Heard Of
3M: Money Making Machine Or Much More Malaise
AbbVie Plus Allergan: Reasonable Valuation And Dynamic Dividend Growth
Disney: To Buy Or Not To Buy, That Is The Question
Enbridge: Undervalued, With Returns Like An MLP, And No K-1
Why This AT&T Bear Loaded Up On Ma Bell Stock
Federal Realty: A Company For Your Post-COVID-19 Watch List
Comcast: Weighing The Multiple Headwinds Against The Fruitful Initiatives
Anthem: Undervalued With A Long Growth Runway
CVS Health: Upside Potential With Limited Risk